This Day On The Street
Continue to site right-arrow
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Palomar Medical Technologies CEO Discusses Q3 2010 Results – Earnings Call Transcript

Palomar Medical Technologies Inc. ( PMTI)

Q3 2010 Earnings Call

October 28, 2010; 11:30 am ET


Joe Caruso - President & Chief Executive Officer

Paul Weiner, Chief Financial Officer

Dan Valente - Chairman

Kerry McAnistan - Investor Relations Assistant


Dalton Chandler - Needham

Anthony Vendetti - Maxim Group

Jose Haresco - JMP Securities

Sharon DeStefano - Argent LLC

Bill Plovanic - Canaccord Genuity

Andy Schopick - Nutmeg Securities



Welcome to the Palomar Medical Technologies third quarter 2010 financial results conference call. Please be aware that each of your lines is in a listen-only mode. At the conclusion of Palomar’s presentation, we will open the floor for questions. At that time, instructions will be given as to the procedure to follow if you would like to ask a question.

I would now like to turn the conference over to Kerry McAnistan, Investor Relations Assistant at Palomar. Ms. McAniston, you may begin.

Kerry McAnistan

Good morning and welcome to the Palomar Medical Technologies third quarter 2010 conference call. Before we start this morning's call there are a couple of items we would like to cover. These conference calls are recorded live and you may access the webcast replay at Palomar’s website,, through Thursday, November 4th.

Various remarks that we’ll make about future expectations, plans and prospects for the company constitute forward-looking statements, the purposes of the Safe Harbor provisions under the Private Securities Litigation Reform Act of 1995. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors, including those discussed in the Form 10-K for the year ended December 31, 2009 and the company's Quarterly Reports on Form 10-Q, which are on file with the SEC and available through Palomar's website.

1 of 3

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!


DOW 17,698.18 -77.94 -0.44%
S&P 500 2,059.69 -8.20 -0.40%
NASDAQ 4,880.2280 -20.6570 -0.42%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs